Scarborough Advisors’s Organon & Co OGN Stock Holding History

Scarborough Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-24	Closed	-$144	–	506
2026 Q1	$144	Hold	24	–	–	﹤0.01%	721
2025 Q4	$172	Hold	24	–	–	﹤0.01%	430
2025 Q3	$256	Hold	24	–	–	﹤0.01%	437
2025 Q2	$232	Buy	+24	New	+$248	﹤0.01%	427
2024 Q3	–	Sell	-13	Closed	-$269	–	339
2024 Q2	$269	Sell	13 -3	-19%	-$60	﹤0.01%	396
2024 Q1	$301	Sell	16 -2	-11%	-$34	﹤0.01%	374
2023 Q4	$260	Buy	+18	New	+$245	﹤0.01%	682

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Scarborough Advisors's OGN Position: Q2 2026 in Review

Scarborough Advisors sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 24 shares — an estimated $144 sold.

Scarborough Advisors first reported a position in OGN in Q4 2023 and held it in 7 quarters. The position peaked at $301 in Q1 2024. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Scarborough Advisors reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
Scarborough Advisors sold 24 Organon & Co shares in Q2 2026, an estimated $144.
Scarborough Advisors first reported a position in Organon & Co in Q4 2023 and held it in 7 quarters.
Scarborough Advisors's Organon & Co position peaked at $301 in Q1 2024.
627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.